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Objectives: Carbapenem-hydrolysing class D b-lactamases of the OXA-48 type are increasingly reported
from Enterobacteriaceae. b-Lactamase OXA-48 hydrolyses penicillins very efﬁciently, but carbapenems only
weakly and spares broad-spectrum cephalosporins. Recently, diverse OXA-48-like b-lactamases have been
identiﬁed worldwide (OXA-162, OXA-181, OXA-163, OXA-204 and OXA-232). They differ by few amino acid
substitutions or by amino acid deletions.
Methods: blaOXA-48, blaOXA-162, blaOXA-163, blaOXA-181, blaOXA-204 and blaOXA-232 were cloned into the same
expression vector and expressed in the same Escherichia coli background. Kinetic studies were performed with
enzymes puriﬁed by ion-exchange chromatography. Determination of hydrolytic activities was performed by
UV spectrophotometry. MICs were determined for all recombinant strains, using as background either the WT
E. coli TOP10 strain or a porin-deﬁcient E. coli strain.
Results: Kinetic studies showed that OXA-162 and OXA-204 shared the same hydrolytic properties as OXA-48.
On the other hand, OXA-181 possessed a higher ability to hydrolyse carbapenems, while OXA-232 hydrolysed
those substrates less efﬁciently. In contrast to the other OXA-48-like b-lactamases, OXA-163 hydrolysed
broad-spectrum cephalosporins very efﬁciently, but did not possess signiﬁcant carbapenemase activity.
Although several of these OXA-48-like enzymes possess low activity against carbapenems, MICs of carbapenems
were signiﬁcantly elevated when determined for strains possessing permeability defects.
Conclusions: A detailed comparative analysis of the kinetic properties of the OXA-48-like b-lactamases is
provided here. It clariﬁes the respective features of each OXA-48-like variant and their respective impacts in
terms of carbapenem resistance.
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Introduction
The emerging mechanism of resistance to carbapenems
in Enterobacteriaceae is related to the horizontal transfer of
plasmid-mediated carbapenemase genes.1,2 Carbapenemases
belong to the Ambler class A, B or D b-lactamases.3 OXA-48
and its derivatives are class D b-lactamases and have dis-
seminated widely, but only in Enterobacteriaceae.4,5 They are
widespread in particular in Europe, Africa and the Indian subcon-
tinent.1 b-Lactamase OXA-48 hydrolyses penicillins at a high
level and carbapenems at a low level, but spares expanded-
spectrum cephalosporins such as ceftazidime.5 Due to these
properties, OXA-48 producers may be either susceptible or
resistant to broad-spectrum cephalosporins (additional produc-
tion of an ESBL observed in 80% of strains6,7) and to carbape-
nems. Indeed, additional mechanisms such as permeability
defects, efﬂux overproduction and high-level production of
expanded-spectrum b-lactamases (AmpC and ESBLs) have
been shown to confer reduced susceptibility to carbapenems
when combined.5
Since the ﬁrst identiﬁcation of OXA-48,8 different variants have
been reported, differing by few amino acid substitutions or dele-
tions.5 Whereas some OXA-48-related enzymes such as OXA-48,
OXA-162, OXA-181, OXA-204 and OXA-232 have been reported as
conferring a very similar resistance pattern, OXA-163 (with a
single amino acid substitution together with a four amino acid
1
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deletion compared with OXA-48) compromises the efﬁcacy of
broad-spectrum cephalosporins and hydrolyses carbapenems
only marginally.9 From a biochemical point of view, these
OXA-48-like b-lactamases have not been puriﬁed and analysed
under the same conditions. This may create misleading inter-
pretations when comparing the respective kinetic data, since
values are known to vary under different experimental conditions
(e.g. buffer content and concentration for hydrolysis assays, reac-
tion temperature and type of UV spectrophotometer). Similarly,
since expression of the different blaOXA-48-like genes has
been evaluated using different cloning vectors and different
Escherichia coli host strains, MIC interpretations might again be
misleading when comparing the susceptibility of the different
recombinant strains. Therefore, and in order to gain further
insights into the relative hydrolytic properties of these different
variants, we designed a study aiming to clone and express in
the same genetic background a series of blaOXA-48-like genes.
Here, we evaluated the susceptibility of the corresponding recom-
binant clones to b-lactams, including temocillin, which is reported
to be a good substrate of OXA-48 and therefore used as a marker
for the detection of OXA-48-like producers.10 Additionally, the
relative catalytic activities of puriﬁed enzymes and the perform-
ance of the Carba NP test were tested for these OXA-48-like
b-lactamases.
Materials and methods
Bacterial strains
A series of clinical Klebsiella pneumoniae isolates harbouring blaOXA-48-like
genes were used as templates. These isolates respectively harboured
genes encoding OXA-162 (France, 2013),7 OXA-163 (Argentina, 2011),9
OXA-181 (France 2013),11 OXA-204 (France, 2013)12 and OXA-232
(India, 2012).13 These variants differed from OXA-48 by a single
amino acid substitution or by amino acid deletions (Figure 1). E. coli
TOP10 was used as a recipient strain for cloning and expressing the
different blaOXA-48-like genes as described previously.
12 In addition,
E. coli HB4 lacking the major porins OmpF and OmpC was also used as
a recipient strain to evaluate the relative impact of the expression of
these genes in an E. coli reference strain with low-level outer membrane
permeability.14
Cloning and expression of the blaOXA-48-like genes
The entire coding sequences of the b-lactamase genes (blaOXA-162,
blaOXA-163, blaOXA-181, blaOXA-204 and blaOXA-232) were obtained by PCR
ampliﬁcation using primers OXA-48A (5′-TTGGTGGCATCGATTATCGG-3′)
and OXA-48B (5′-GAGCACTTCTTTTGTGATGGC-3′) and were then inserted
into plasmid pCRw-Blunt II-TOPOw (Invitrogen, Illkirch, France) for
the phenotypic studies and pET9a (Novagen, VWR International,
Fontenay-sous-Bois, France) following the manufacturer’s recommenda-
tions. Recombinant plasmids obtained with pCRw-Blunt II-TOPOw were
transformed into either E. coli strain TOP10 or E. coli strain HB4. The orien-
tation of the respective inserts was checked by sequencing to ensure all
genes were under the control of the Plac promoter. Recombinant plasmids
constructed in plasmid pET9a (Stratagene, Amsterdam, the Netherlands)
used as expression vector and then were transformed into E. coli strain
BL21(DE3) (Novagen) following the manufacturer’s recommendations.
b-Lactamase puriﬁcation
An overnight culture of E. coli strain BL21 harbouring pET9a-derived
recombinant plasmids was used to inoculate 2 L of LB medium broth con-
taining 50 mg/L kanamycin. Bacteria were cultured at 378C until reaching
Figure 1. Amino acid alignment of OXA-48 and six other variants. Dashes indicate identical residues among all amino acid sequences. Slashes indicate
the absence of amino acids. Amino acid motifs that are well conserved among class D b-lactamases are indicated by boxes. Numbering is according to
class D b-lactamase (DBL nomenclature).17
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an OD of 0.6 at 600 nm. Then, expression of the b-lactamase genes was
carried out overnight at 258C with 0.1 mM IPTG as inducer. Cultures were
centrifuged at 6000 g for 15 min and then the pellets were resuspended
with 10 mL of 20 mM triethanolamine H2SO4 (pH 7.2). Bacterial cells were
disrupted by sonication and the bacterial pellet was removed by two con-
secutive centrifugation steps at 10000 g for 1 h at 48C and then the super-
natant was centrifuged at 48000 g for 1 h at 48C. b-Lactamases were
puriﬁed by using two successive steps of anion-exchange chromatography
[20 mM triethanolamine H2SO4 (pH 7.2) and then 20 mMpiperazine H2SO4
(pH 9.5)] using Q-Sepharose columns, followed by a gel ﬁltration step
[100 mM sodium phosphate buffer (pH 7) and 150 mM K2SO4]. Peaks of
b-lactamase activity were concentrated by using Vivaspinw columns (GE
Healthcare, Freiburg, Germany) and dialysed with 100 mM sodium phos-
phate buffer (pH 7). Protein purity was estimated by SDS–PAGE.
Kinetic studies
Puriﬁed b-lactamases were used for kinetic measurements, which were
determined at 308C in 100 mM Tris-H2SO4 and 300 mM K2SO4 (pH 7).
The kcat and Km values were determined by analysing b-lactam hydroly-
sis under initial-rate conditions with an ULTROSPEC 2000 model UV
spectrophotometer (Amersham Pharmacia Biotech) using the Eadie–
Hoffstee linearization of the Michaelis–Menten equation. The different
b-lactams were purchased from Sigma–Aldrich (Saint-Quentin-
Fallavier, France).
Susceptibility testing
The susceptibility pattern was determined by the disc diffusion method
and MICs by the microbroth dilution method. Results were interpreted
according to CLSI guidelines.15 MICs were determined only for clones har-
bouring recombinant pCRw-Blunt II-TOPOw plasmids and transformed into
either E. coli TOP10 or E. coli HB4 strains.
Results and discussion
Susceptibility patterns of the recombinant strains
expressing the OXA-48-like b-lactamases
MIC determination for E. coli recombinants always showed high-
level resistance to ampicillin and temocillin (Table 1). A signiﬁcant
decreased susceptibility to carbapenems was noticed for all
clones (4- to 16-fold increase), with the exception of the clone
producing OXA-163 with only a 2-fold increase in MICs of imipe-
nem and doripenem, although the MIC of meropenem remained
unchanged. Notably, the recombinant strain producing OXA-181
showed the highest MICs of carbapenems, while almost identical
values were obtained for OXA-48, OXA-162 and OXA-204 pro-
ducers. Lower MICs were obtained for the OXA-232 producer,
suggesting lower hydrolytic activity of that variant towards
carbapenems (Table 1).
Recombinant strains producing OXA-163 or OXA-232 had
lower MICs of temocillin than those producing other OXA-48 deri-
vatives. This result might have a signiﬁcant impact considering
that several screening techniques of OXA-48-like producing iso-
lates now rely on this peculiar property.
As previously noted, the OXA-163 producer was the only
OXA-48-like producer exhibiting elevated MICs of broad-spectrum
cephalosporins such as cefotaxime and ceftazidime. Ta
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Impact of the OXA-48-like b-lactamases in a
porin-deﬁcient E. coli background
Expression of the blaOXA-48-like genes in E. coli HB4 gave rise to
higher MICs of carbapenems compared with those MICs obtained
for E. coli TOP10 (Table 1). Notably, production of OXA-163
increased the MIC of imipenem only slightly although those of
other carbapenems, in particular ertapenem, increased more sig-
niﬁcantly. This result further conﬁrms that OXA-163 is a very weak
carbapenemase that does impact the activity of carbapenems
only slightly in the absence of additional mechanisms of
resistance.
Notably, despite conferring similar resistance patterns, dis-
crepancies among the different OXA-48-like enzymes were high-
lighted here. For example, MICs of carbapenems were much
higher for OXA-181 than for OXA-232 when produced in E. coli
HB4 (128 versus 16 mg/L) (Table 1).
Hydrolytic properties of OXA-48-like b-lactamases
Kinetic studies were performed with puriﬁed OXA-48-like
b-lactamases in order to compare their relative catalytic proper-
ties. The hydrolysis rates of puriﬁed OXA-162, OXA-181 and
OXA-204 enzymes for all b-lactams tested were very similar to
those obtained with OXA-48 (Table 2). These results are in accord-
ancewith MIC data showing very similar susceptibility patterns for
the different E. coli clones producing OXA-48, OXA-162, OXA-181
and OXA-204, respectively (Table 2). Unlike other variants,
OXA-232 had a catalytic activity for temocillin that was
10-fold lower than that of OXA-48, while hydrolysis of temocillin
by OXA-163 remained undetectable. The hydrolysis rates of car-
bapenems by OXA-232 were signiﬁcantly lower than those
obtained for OXA-48, OXA-162, OXA-181 and OXA-204 (Table 2).
Biochemical analysis of the hydrolytic properties of OXA-163
conﬁrmed that it is an ESBL hydrolysing cefotaxime and ceftazi-
dime efﬁciently, but carbapenems only marginally.
Conclusions
Several biochemical features of the different OXA-48-like
b-lactamases were compared. The results showed that this
group of enzymes, although being quite homogeneous in
terms of protein sequence, is rather heterogeneous in terms of
hydrolytic proﬁle. Indeed, and as opposed to what was initially
considered, this group of enzymes does not encompass only car-
bapenemases. It was shown that subtle amino acid changesmay
basically confer different substrate speciﬁcities, with some var-
iants being either ESBLs or true carbapenemases. Therefore,
detection of those genes encoding OXA-48-like enzymes posses-
sing carbapenemase activities only cannot rely on PCR-based
ampliﬁcation of those genes only. Complete sequencing of the
corresponding genes is therefore required to extrapolate the
kinetic proﬁle of the corresponding enzymes.
In addition, we showed here that additional non-enzymatic
resistance mechanisms are required in order to achieve high
MIC values of carbapenems for most OXA-48-like producers and
that the resistance levels obtained in a porin-deﬁcient E. coli back-
ground are variable depending on the nature of the OXA-48-like
variant.
Additionally, we showed that high-level resistance to temo-
cillin is not a common feature for all OXA-48-like producers. Ta
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However, resistance to carbapenems correlates well with the
carbapenemase activity of these different enzymes. OXA-163
(without any signiﬁcant carbapenemase activity) and OXA-232
(with weaker carbapenemase activity compared with other
OXA-48-like enzymes) hydrolysed temocillin weakly and corre-
sponding producers did not exhibit high MICs of that antibiotic.
This suggests that detection and screening strategies based on
temocillin resistance are valid for OXA-48-like enzymes with sig-
niﬁcant carbapenemase activity only. On the other hand, the
Carba NP test16 is an excellent tool for evaluating the carbapene-
mase activity of these OXA-48-like enzymes.
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